Back
ESC Premium Access

Prescription of guideline recommended oral anticoagulation and reasons reported for non-use of OAC in patients with atrial fibrillation: Data from the German AFNET-2 Registry

Session: Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms
Topic: Epidemiology, Prognosis, Outcome
Speaker: Professor M. Naebauer (Munich, DE)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Michael Naebauer

Ludwig-Maximilians University, Munich (Germany)
0 follower

9 more presentations in this session

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Speaker: Doctor E. Mironova (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Speaker: Doctor T. Tu (Changsha, CN)

Access
Abstract
Slides
Thumbnail

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Speaker: Professor G. Tse (Hong Kong, CN)

Access
Abstract
Thumbnail

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Speaker: Doctor N. Kazem (Vienna, AT)

Access
Abstract
Slides
Thumbnail

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

Speaker: Doctor P. Buettner (Leipzig, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Speakers: Professor M. Naebauer, Doctor E. Mironova, Doctor T. Tu, Professor G. Tse, Doctor N. Kazem...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb